Tissue-Based Markers as a Tool to Assess Response to Neoadjuvant Radiotherapy in Rectal Cancer—Systematic Review

According to current guidelines, the current treatment for locally advanced rectal cancer is neoadjuvant therapy, followed by a total mesorectal excision. However, radiosensitivity tends to differ among patients due to tumor heterogeneity, making it difficult to predict the possible outcomes of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Smolskas, Edgaras, Mikulskytė, Goda, Sileika, Ernestas, Suziedelis, Kestutis, Dulskas, Audrius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181431/
https://www.ncbi.nlm.nih.gov/pubmed/35682714
http://dx.doi.org/10.3390/ijms23116040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181431/
https://www.ncbi.nlm.nih.gov/pubmed/35682714
http://dx.doi.org/10.3390/ijms23116040

Ejemplares similares